Skip to content

Whether herbal eye drops help in management of dry eye syndrome ?

"Role of Rajnidaaru eye drops and Rasayan Churna in the management of Shushkaakshipaka (Dry eye syndrome) - An open label double arm randomized clinical trialâ??

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/03/012530
Enrollment
30
Registered
2018-03-13
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Patients with sign and symptoms of shuskakshipaaka (dry eye syndrome)

Interventions

Intervention1: Rajnidaaru Eyedrop: 2 drops in both eyes will be administered twice a day for 42 days. Control Intervention1: Rajnidaaru eyedrop with Rasayan Churna: 2 drops in both eyes will be admini

Sponsors

All india Institute of Ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients of either sex aged up to18 - 60 years. 2.Patients presenting with signs and symptoms of Dry eye syndrome. 3.Willing and able to participate in the study.

Exclusion criteria

Exclusion criteria: 1.Age group less than 18 and more than 60 years. 2.Severe cases of dry eye syndrome with complications like perforated corneal ulcer, Uveitis, Glaucoma. 3.Allergic eye disease i.e. vernal keratoconjunctivitis, Giant papillary conjunctivitis. 4.Non specific topical beta blocker users. 5.Inflammatory conditions like acute conjunctivitis. 6.Patients on steroids, oral contraceptive pills, estrogen replacement therapy or any other medication such as antispasmodic drugs like Atropine that may adversely affect the outcome of the study. 7.Patients suffering from major systemic illness necessitating long term drug treatment i.e. Psycho-epileptic drug users. 8.H/o hypersensitivity to the trial drug or any of its ingredients. 9.Persistent Contact Lens Users.

Design outcomes

Primary

MeasureTime frame
Reduction in clinical features of dry eye syndromeTimepoint: The patients will be assesed at the end of the study

Secondary

MeasureTime frame
Changes in the quality of lifeTimepoint: The patients will be assesed at the end of the study

Countries

India

Contacts

Public ContactDr Neeraj Dubey

All india institue of ayurveda

dubenrj@gmail.com8285520530

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026